Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma

Fanconi anemia (FA) patients display an exacerbated risk of oral squamous cell carcinoma (OSCC) and oral potentially malignant lesions (OPMLs) at early ages. As patients have defects in their DNA repair mechanisms, standard-of-care treatments for OSCC such as radiotherapy and chemotherapy, give rise...

Full description

Bibliographic Details
Main Authors: Ricardo Errazquin, Estela Carrasco, Sonia Del Marro, Anna Suñol, Jorge Peral, Jessica Ortiz, Juan Carlos Rubio, Carmen Segrelles, Marta Dueñas, Alicia Garrido-Aranda, Martina Alvarez, Cristina Belendez, Judith Balmaña, Ramon Garcia-Escudero
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/15/6/1871
_version_ 1797612921748979712
author Ricardo Errazquin
Estela Carrasco
Sonia Del Marro
Anna Suñol
Jorge Peral
Jessica Ortiz
Juan Carlos Rubio
Carmen Segrelles
Marta Dueñas
Alicia Garrido-Aranda
Martina Alvarez
Cristina Belendez
Judith Balmaña
Ramon Garcia-Escudero
author_facet Ricardo Errazquin
Estela Carrasco
Sonia Del Marro
Anna Suñol
Jorge Peral
Jessica Ortiz
Juan Carlos Rubio
Carmen Segrelles
Marta Dueñas
Alicia Garrido-Aranda
Martina Alvarez
Cristina Belendez
Judith Balmaña
Ramon Garcia-Escudero
author_sort Ricardo Errazquin
collection DOAJ
description Fanconi anemia (FA) patients display an exacerbated risk of oral squamous cell carcinoma (OSCC) and oral potentially malignant lesions (OPMLs) at early ages. As patients have defects in their DNA repair mechanisms, standard-of-care treatments for OSCC such as radiotherapy and chemotherapy, give rise to severe toxicities. New methods for early diagnosis are urgently needed to allow for treatment in early disease stages and achieve better clinical outcomes. We conducted a prospective, longitudinal study wherein liquid biopsies from sixteen patients with no clinical diagnoses of OPML and/or OSCC were analyzed for the presence of mutations in cancer genes. The DNA from saliva and plasma were sequentially collected and deep-sequenced, and the clinical evaluation followed over a median time of approximately 2 years. In 9/16 FA patients, we detected mutations in cancer genes (mainly <i>TP53</i>) with minor allele frequencies (MAF) of down to 0.07%. Importantly, all patients that had mutations and clinical follow-up data after mutation detection (<i>n</i> = 6) developed oral precursor lesions or OSCC. The lead-time between mutation detection and tumor diagnosis ranged from 23 to 630 days. Strikingly, FA patients without mutations displayed a significantly lower risk of developing precursor lesions or OSCCs. Therefore, our diagnostic approach could help to stratify FA patients into risk groups, which would allow for closer surveillance for OSCCs or precursor lesions.
first_indexed 2024-03-11T06:48:42Z
format Article
id doaj.art-809927a916354dc9b9a99866451b903b
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-11T06:48:42Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-809927a916354dc9b9a99866451b903b2023-11-17T10:08:21ZengMDPI AGCancers2072-66942023-03-01156187110.3390/cancers15061871Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and PlasmaRicardo Errazquin0Estela Carrasco1Sonia Del Marro2Anna Suñol3Jorge Peral4Jessica Ortiz5Juan Carlos Rubio6Carmen Segrelles7Marta Dueñas8Alicia Garrido-Aranda9Martina Alvarez10Cristina Belendez11Judith Balmaña12Ramon Garcia-Escudero13Research Institute Hospital 12 de Octubre (Imas12), University Hospital 12 de Octubre, Av Cordoba s/n, 28041 Madrid, SpainHereditary Cancer Genetics Group, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, SpainMolecular Oncology Unit, CIEMAT (Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas), Avenida Complutense 40, 28040 Madrid, SpainHereditary Cancer Genetics Group, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, SpainMolecular Oncology Unit, CIEMAT (Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas), Avenida Complutense 40, 28040 Madrid, SpainMolecular Oncology Unit, CIEMAT (Centro de Investigaciones Energeticas, Medioambientales y Tecnologicas), Avenida Complutense 40, 28040 Madrid, SpainResearch Institute Hospital 12 de Octubre (Imas12), University Hospital 12 de Octubre, Av Cordoba s/n, 28041 Madrid, SpainResearch Institute Hospital 12 de Octubre (Imas12), University Hospital 12 de Octubre, Av Cordoba s/n, 28041 Madrid, SpainResearch Institute Hospital 12 de Octubre (Imas12), University Hospital 12 de Octubre, Av Cordoba s/n, 28041 Madrid, SpainCentro de Investigaciones Médico-Sanitarias (CIMES), 29071 Malaga, SpainCentro de Investigaciones Médico-Sanitarias (CIMES), 29071 Malaga, SpainCentro de Investigación Biomédica en Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, SpainHereditary Cancer Genetics Group, Medical Oncology Department, Vall d’Hebron Institute of Oncology (VHIO), 08035 Barcelona, SpainResearch Institute Hospital 12 de Octubre (Imas12), University Hospital 12 de Octubre, Av Cordoba s/n, 28041 Madrid, SpainFanconi anemia (FA) patients display an exacerbated risk of oral squamous cell carcinoma (OSCC) and oral potentially malignant lesions (OPMLs) at early ages. As patients have defects in their DNA repair mechanisms, standard-of-care treatments for OSCC such as radiotherapy and chemotherapy, give rise to severe toxicities. New methods for early diagnosis are urgently needed to allow for treatment in early disease stages and achieve better clinical outcomes. We conducted a prospective, longitudinal study wherein liquid biopsies from sixteen patients with no clinical diagnoses of OPML and/or OSCC were analyzed for the presence of mutations in cancer genes. The DNA from saliva and plasma were sequentially collected and deep-sequenced, and the clinical evaluation followed over a median time of approximately 2 years. In 9/16 FA patients, we detected mutations in cancer genes (mainly <i>TP53</i>) with minor allele frequencies (MAF) of down to 0.07%. Importantly, all patients that had mutations and clinical follow-up data after mutation detection (<i>n</i> = 6) developed oral precursor lesions or OSCC. The lead-time between mutation detection and tumor diagnosis ranged from 23 to 630 days. Strikingly, FA patients without mutations displayed a significantly lower risk of developing precursor lesions or OSCCs. Therefore, our diagnostic approach could help to stratify FA patients into risk groups, which would allow for closer surveillance for OSCCs or precursor lesions.https://www.mdpi.com/2072-6694/15/6/1871Fanconi anemiahead and neck squamous cell carcinomaoral squamous cell carcinomaOSCCSCCoral potentially malignant lesion
spellingShingle Ricardo Errazquin
Estela Carrasco
Sonia Del Marro
Anna Suñol
Jorge Peral
Jessica Ortiz
Juan Carlos Rubio
Carmen Segrelles
Marta Dueñas
Alicia Garrido-Aranda
Martina Alvarez
Cristina Belendez
Judith Balmaña
Ramon Garcia-Escudero
Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
Cancers
Fanconi anemia
head and neck squamous cell carcinoma
oral squamous cell carcinoma
OSCC
SCC
oral potentially malignant lesion
title Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
title_full Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
title_fullStr Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
title_full_unstemmed Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
title_short Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma
title_sort early diagnosis of oral cancer and lesions in fanconi anemia patients a prospective and longitudinal study using saliva and plasma
topic Fanconi anemia
head and neck squamous cell carcinoma
oral squamous cell carcinoma
OSCC
SCC
oral potentially malignant lesion
url https://www.mdpi.com/2072-6694/15/6/1871
work_keys_str_mv AT ricardoerrazquin earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT estelacarrasco earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT soniadelmarro earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT annasunol earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT jorgeperal earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT jessicaortiz earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT juancarlosrubio earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT carmensegrelles earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT martaduenas earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT aliciagarridoaranda earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT martinaalvarez earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT cristinabelendez earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT judithbalmana earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma
AT ramongarciaescudero earlydiagnosisoforalcancerandlesionsinfanconianemiapatientsaprospectiveandlongitudinalstudyusingsalivaandplasma